Histone H3 phosphorylation - a versatile chromatin modification for different occasions.

Biochimie
Anna Sawicka, Christian Seiser

Abstract

Post-translation modifications of histones modulate the accessibility and transcriptional competence of specific chromatin regions within the eukaryotic genome. Phosphorylation of histone H3 is unique in the sense that it associates on one hand with open chromatin during gene activation and marks on the other hand highly condensed chromatin during mitosis. Phosphorylation of serine residues at histone H3 is a highly dynamic process that creates together with acetylation and methylation marks at neighboring lysine residues specific combinatorial patterns that are read by specific detector proteins. In this review we describe the importance of different histone H3 phosphorylation marks for chromatin condensation during mitosis. In addition, we review the signals that trigger histone H3 phosphorylation and the factors that control this reversible modification during interphase and mediate the biological readout of the signal. Finally, we discuss different models describing the role of histone H3 phosphorylation in the activation of transcription of poised genes or by transient derepression of epigenetically silenced genes. We propose that histone H3 phosphorylation in the context with lysine methylation might temporarily relieve t...Continue Reading

References

Mar 1, 1978·European Journal of Biochemistry·L R GurleyR A Tobey
Jan 1, 1989·Nucleic Acids Research·D Wells, C McBride
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·M J BarrattL C Mahadevan
Jun 24, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y WeiC D Allis
Jul 7, 2001·The Journal of Biological Chemistry·S ZhongZ Dong
Aug 11, 2001·Science·T Jenuwein, C D Allis
Oct 23, 2002·Molecular and Cellular Biology·Christoph HauserChristian Seiser
Jan 16, 2003·Cell·Stuart L Schreiber, Bradley E Bernstein
Feb 1, 2003·Nucleic Acids Research·Ute PreussKarl Heinz Scheidtmann
Oct 3, 2003·Nature·Wolfgang FischleC David Allis
Oct 17, 2003·Current Biology : CB·Barbara G MelloneRobin C Allshire
Nov 5, 2003·Gene·Shen-Hsi YangAlan J Whitmarsh
Apr 24, 2004·EMBO Reports·Bogdan MateescuChristian Muchardt
Aug 3, 2004·Journal of Cell Science·John W Edmunds, Louis C Mahadevan
May 17, 2005·Brain Research. Molecular Brain Research·Daniel Heffron, James W Mandell
Sep 28, 2005·Biochemistry·Benjamin A GarciaDonald F Hunt
Dec 13, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Karen Brami-CherrierJocelyne Caboche
Jul 29, 2006·Science·Dmitry K PokholokRichard A Young
Aug 4, 2006·Methods : a Companion to Methods in Enzymology·Amparo Pascual-AhuirMarkus Proft
Aug 29, 2006·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Kirk J McManus, Michael J Hendzel
Feb 27, 2007·Cell·Tony Kouzarides
Feb 27, 2007·Cell·Bernd SchuettengruberGiacomo Cavalli

❮ Previous
Next ❯

Citations

Mar 23, 2013·Cell Death and Differentiation·S HagemannH A Baba
Jun 27, 2013·Proceedings of the National Academy of Sciences of the United States of America·Muzaffar AliTatiana G Kutateladze
Apr 24, 2014·Nature Reviews. Molecular Cell Biology·Philipp A Steffen, Leonie Ringrose
Feb 4, 2014·Neuropharmacology·Alessandro Ciccarelli, Maurizio Giustetto
May 13, 2014·Cell and Tissue Research·Detlef Doenecke
Sep 10, 2014·The Journal of Cell Biology·Alexandra N ElsingLea Sistonen
Jan 5, 2016·ACS Chemical Biology·Forest H AndrewsTatiana G Kutateladze
Mar 15, 2016·Frontiers in Plant Science·Pavel NeumannJiří Macas
Jun 21, 2015·Genomics, Proteomics & Bioinformatics·Jing ZhangKenneth B Storey
Jul 22, 2014·Proteomics·Yan-Ming XuAndy T Y Lau
Mar 29, 2014·Reviews in Medical Virology·Shanshan LiYi Zheng
Apr 22, 2014·Biochimica Et Biophysica Acta·Anna Sawicka, Christian Seiser
Mar 27, 2016·Nucleic Acids Research·Jovylyn GatchalianTatiana G Kutateladze
May 29, 2016·Mutation Research. Reviews in Mutation Research·Zeenat FarooqMohammad Altaf
Jul 23, 2014·British Journal of Pharmacology·M RemelyA G Haslberger
Aug 5, 2015·Biotechnology Advances·Rakesh Srivastava, Seong Hoon Ahn
Jun 11, 2015·Biomolecular Concepts·Marlene RemelyAlexander G Haslberger
Jun 15, 2015·Progress in Neurobiology·Roy LardenoijeBart P F Rutten
May 27, 2014·Cell·Grigory KrapivinskyDavid E Clapham
May 24, 2015·Current Opinion in Clinical Nutrition and Metabolic Care·Marlene RemelyAlexander G Haslberger
Feb 8, 2014·Epigenetics : Official Journal of the DNA Methylation Society·José A JarilloManuel Piñeiro
Dec 19, 2013·Bioorganic & Medicinal Chemistry Letters·Jeroen van AmeijdeRob M J Liskamp
Jul 9, 2013·Cell Reports·Jovylyn GatchalianTatiana G Kutateladze
Mar 5, 2014·BioMed Research International·Ruichuan ChenSheng-Hao Chao
Sep 18, 2012·Biochimie·Paola B ArimondoJorg Tost
Aug 19, 2014·Neurobiology of Learning and Memory·Timothy J Jarome, Farah D Lubin
Jan 9, 2015·The Journal of Allergy and Clinical Immunology·Hani Harb, Harald Renz
Aug 20, 2014·Genome Research·Anna SawickaChristian Seiser
Nov 3, 2016·Current Opinion in Pediatrics·Hani HarbDaniel P Potaczek
Jan 17, 2017·Nature Communications·Inês J de CastroPaola Vagnarelli
Oct 19, 2017·Development·Nicola FestucciaPablo Navarro
Sep 14, 2017·RNA Biology·Aerin YangHee-Sung Park
Dec 21, 2016·Applied Immunohistochemistry & Molecular Morphology : AIMM·Judit BedekovicsGábor Méhes
Feb 13, 2016·Microbiology and Molecular Biology Reviews : MMBR·Monika SchmollAlfredo Herrera-Estrella

❮ Previous
Next ❯

Methods Mentioned

BETA
immunoprecipitation
ChIP
acetylation
histone acetylation

Related Concepts

Related Feeds

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.